PDI 2009 ISDP LAC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Perit Dial Int 2(2): 73-76 1982
© 1982 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paton, T. W.
Right arrow Articles by Walker, S. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Paton, T. W.
Right arrow Articles by Walker, S. E.

REVIEWS AND ORIGINAL ARTICLES

CIMETIDINE DISPOSITION IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS

Thomas W. Paton, M. Arifie Manuel and Scott E. Walker

From the Department of Phannacy and Division of Nephrology, Department of Medicine, University of Toronto, Sunnybrook Medical Center, Toronto, Ontario, Canada.

The disposition of cimetidine was studied following a single intravenous dose of 300 mg over 10 minutes in six male patients with end-stage renal disease on continuous ambulatory peritoneal dialysis (CAPD). The infusion of cimetidine and CAPD were initiated simultaneously. Cimetidine disappearance from plasma was biphasic with beta-phase ti varying from 6.1 to 7.4 hours. The total body clearance varied from 138 to 195 ml/min with a peritoneal clearance ranging from 1.9 to 4.0 ml/min. The total amount of cimetidine removed in the dialysate varied from 3.1 to 8.3 mg (1.2 to 2.7% of the dose administered) over 24 hours. This study demonstrates that very little cimetidine is removed by CAPD. We recommend that, to avoid toxicity, patients on CAPD should be given 200 mg cimetidine every 12 hours.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 1982 by Multimed Inc.